Abstract:ABSTRACT Most people infected with Mycobacterium tuberculosis ( Mtb ) are believed to be in a state of latent tuberculosis (TB) infection (LTBI). Although LTBI is asymptomatic and not infectious, there is a risk of developing active disease even decades after infection. Here, to characterize mutations acquired during LTBI, we collected and analyzed Mtb genomes from seven Japanese patient pairs, each pair consisting of two active TB patients whose starting dates of developing active disease were >3 years apart; one had a high suspicion of LTBI before developing active disease, whereas the other did not. Thereafter, we compared these genomes with those of longitudinal sample pairs within a host of chronic active TB infections combined with public data. The bacterial populations in patients with LTBI were genetically more homogeneous and accumulated single nucleotide polymorphisms (SNPs) slower than those from active disease. Moreover, the lower proportion of nonsynonymous SNPs indicated weaker selective pressures during LTBI than active disease. Finally, the different mutation spectrums indicated different mutators between LTBI and active disease. These results suggest that the likelihood of the acquisition of mutations responsible for antibiotic resistance and increased virulence was lower in the Mtb population from LTBI than active disease. IMPORTANCE Controlling latent tuberculosis (TB) infection (LTBI) activation is an effective strategy for TB elimination, where understanding Mycobacterium tuberculosis ( Mtb ) dynamics within the host plays an important role. Previous studies on chronic active disease reported that Mtb accumulated genomic mutations within the host, possibly resulting in acquired drug resistance and increased virulence. However, several reports suggest that fewer mutations accumulate during LTBI than during the active disease, but the associated risk is largely unknown. Here, we analyzed the genomic dynamics of Mtb within the host during LTBI. Our results statistically suggest that Mtb accumulates mutations during LTBI, but most mutations are under low selective pressures, which induce mutations responsible for drug resistance and virulence. Thus, we propose that LTBI acts as a source for new TB disease rather than as a period for in-host genome evolution.

A modern view on the mechanism of occurrence and development of latent tuberculosis infection. Literature review

Latent Mycobacterium tuberculosis infection.

Progress on Diagnosis and Treatment of Latent Tuberculosis Infection

Advances in Understanding Immune Homeostasis in Latent Tuberculosis Infection.

Diagnosis and treatment of latent infection with Mycobacterium tuberculosis.

The definition of tuberculosis infection based on the spectrum of tuberculosis disease

The past, present and future of tuberculosis treatment.

Tuberculosis: Current state of knowledge: An Epilogue

Exploring the link between cardiovascular risk factors and manifestations in latent tuberculosis infection: a comprehensive literature review

Metabolic Versatility of Mycobacterium tuberculosis during Infection and Dormancy

Mycobacterial Dormancy Systems and Host Responses in Tuberculosis

Current Concepts in the Management of Tuberculosis

Mycobacterium tuberculosis is less likely to acquire pathogenic mutations during latent infection than during active disease

Evaluating the significance of latent tuberculosis infection treatment in high‐incidence countries

Prevalence Trends of Latent Tuberculosis Infection at the Global, Regional, and Country Levels from 1990–2019

Research Progress on Genetic Control of Host Susceptibility to Tuberculosis.

Challenges in the Screening and Treatment of Latent Multidrug-Resistant Tuberculosis Infection

Updates on the Risk Factors for Latent Tuberculosis Reactivation and Their Managements.

Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries

Mycobacterium tuberculosis and host interactions in the manifestation of tuberculosis

Editorial: Factors for the Progression from Latent Tuberculosis Infection to Tuberculosis Disease